WW International, Inc.

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

Weight Watchers (NASDAQ: WW) announced a collaboration with Google Health Enterprise combining Fitbit wearable technology and AI-powered health insights with its clinically proven weight health program. Available now through select Weight Watchers for Business client programs, the offering gives eligible members access to Fitbit Air and Google Health Premium after completing activity milestones, with connected activity, sleep, and health insights. No financial terms were disclosed; the partnership positions WW to strengthen employer and payer engagement amid rising demand for GLP-1 support.

•26d ago

WW: 8-K · leadership change

WW International, the company behind WeightWatchers, announced on September 9, 2026 the appointment of Stephen J. Bye as President and Chief Executive Officer and as a director, effective on a mutually agreed date no later than November 27, 2026. The board will expand from six to seven seats when he joins. Bye, 58, was most recently President and CEO of Ookla, whose brands include Speedtest, Downdetector, Ekahau and RootMetrics, where he is credited with growing subscription revenue, improving profitability and integrating acquisitions. He previously served as EVP and Chief Commercial Officer of DISH Network's wireless business and CTO of Sprint, and currently sits on the boards of Inseego and EchoStar. His employment agreement provides an $850,000 base salary, a target bonus of 125% of salary (guaranteed at target for 2026), a $1.5 million signing bonus, a $1 million signing RSU grant and a $5.1 million initial equity grant, plus annual equity grants of at least 300% of salary starting in 2028. A qualifying termination within 24 months of a change in control triggers 2x salary plus target bonus in a lump sum with full equity acceleration. The appointment ends the Interim Office of the Chief Executive, comprised of CFO Felicia DellaFortuna and COO Jonathan Volkmann, which has led the company since April 3, 2026. Both executives return to their existing roles when Bye starts.

SEC 8-K•1mo ago

Weight Watchers Appoints Stephen Bye as Chief Executive Officer

WW International has appointed Stephen Bye as President and CEO and a member of its Board of Directors, with the appointment effective this fall. Bye arrives from Ookla, where as CEO he grew subscription revenue, improved profitability and led multiple acquisition integrations; his background also spans senior roles at DISH Network, Sprint, C Spire and Connectivity Wireless. The board approved the hire unanimously as Weight Watchers builds an integrated weight health platform for the GLP-1 era, with Bye citing the opportunity to combine behavioral coaching, clinical care and GLP-1 access with data-driven technology.

•1mo ago

Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community

WW International announced a summer collaboration with FlavCity, launching a limited-edition Whipped Lemonade protein smoothie powder that contains 25 grams of protein per serving and has a 4 Points value. The partnership includes the introduction of the Summer Strength Club, a 10-week member experience featuring live weekly strength classes and nutritional content designed to build community engagement. Chief Experience Officer Julie Rice emphasized that FlavCity's engaged community makes them a natural partner to help WW members stay on track with their nutrition goals.

•3mo ago

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

WW International launched the Medicare GLP-1 Bridge Program through its Weight Watchers Med+ service, enabling eligible Medicare beneficiaries to purchase GLP-1 weight-loss medications for $50 per month. The program, effective July 1, 2026, through December 31, 2027, covers popular medications like Wegovy and Zepbound and includes comprehensive support for insurance navigation and prior authorizations. Internal company data indicates that Med+ members who engaged with the GLP-1 Success Program lost 29.1% more body weight at 12 months compared to those who did not use the behavioral support tools.

•3mo ago

Weight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight Study

Weight Watchers is partnering with the American Heart Association to recruit members for the Healthy Living BEYOND Weight Study, a nationwide effort to understand long-term outcomes for people with obesity. Internal analysis indicates that Med+ members using GLP-1 medications who engaged in behavioral support lost 61.3% more weight at one month and 29.1% more at twelve months compared to those on medication alone. The collaboration aims to integrate medical care with lifestyle research, expanding data on real-world weight health outcomes.

•4mo ago

Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

WW International expanded its partnership with UK-based digital health platform CheqUp to integrate clinical and behavioral weight management services for UK members. Under the new agreement, WW members can access CheqUp's medical weight-loss consultations, while CheqUp members receive full access to the WW app and its GLP-1 Companion Programme. The expansion leverages the NHS's recent broadening of weight-loss medication access, aiming to replicate the holistic model WW offers in the US market.

•4mo ago

Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect

WW International has integrated its Weight Watchers Med+ program into Eli Lilly’s LillyDirect digital healthcare platform. This partnership allows patients accessing Lilly’s GLP-1 medications to connect directly with WW’s clinical and behavioral support services. The move expands WW’s distribution channel in the rapidly growing obesity care market, leveraging Lilly’s prescription network to drive membership and service adoption.

•4mo ago

Weight Watchers Announces First Quarter 2026 Results

Weight Watchers reported Q1 revenue of $168 million, down 10% year-over-year, driven by a mix shift towards higher-value Clinical subscribers which grew 46% YoY to 197,000. Despite the revenue decline, Adjusted Gross Margin remained near record highs at 73.6% and the company reaffirmed its full-year 2026 guidance for revenue of $620M-$635M and Adjusted EBITDA of $105M-$115M. The company announced a fully subscribed debt prepayment solicitation expected to reduce the principal amount of its term loan by $42 million and lower annualized interest expense by approximately $4 million.

•5mo ago